CaparelloC.; VasileE.; LucchesiM.; GinocchiL.; CaponiS.; LencioniM.; RicciS.; FalconeA. Fixed-Dose Rate Gemcitabine Plus Capecitabine as Second-Line Treatment for Metastatic Pancreatic Cancer Patients Pretreated with Oxaliplatin. JOP. Journal of the Pancreas, v. 13, n. 5S, p. 596, 20 set. 2012.